MCID: VSC007
MIFTS: 67

Vascular Disease malady

Categories: Mental diseases, Gastrointestinal diseases, Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Vascular Disease

Summaries for Vascular Disease

MedlinePlus : 41 the vascular system is the body's network of blood vessels. it includes the arteries, veins and capillaries that carry blood to and from the heart. problems of the vascular system are common and can be serious. arteries can become thick and stiff, a problem called atherosclerosis. blood clots can clog vessels and block blood flow to the heart or brain. weakened blood vessels can burst, causing bleeding inside the body. you are more likely to have vascular disease as you get older. other factors that make vascular disease more likely include family history of vascular or heart diseases pregnancy illness or injury long periods of sitting or standing still any condition that affects the heart and blood vessels, such as diabetes or high cholesterol smoking obesity losing weight, eating healthy foods, being active and not smoking can help vascular disease. other treatments include medicines and surgery.

MalaCards based summary : Vascular Disease, also known as vascular diseases, is related to capillary hemangioma and lupus erythematosus, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Vascular Disease is MTHFR (Methylenetetrahydrofolate Reductase), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Development VEGF signaling via VEGFR2 - generic cascades. The drugs Acetazolamide and Methyltestosterone have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and spinal cord, and related phenotypes are Decreased free cholesterol and Increased LDL uptake

Disease Ontology : 12 A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart.

Wikipedia : 71 Vascular disease is a class of diseases of the blood vessels – the arteries and veins of the... more...

Related Diseases for Vascular Disease

Diseases related to Vascular Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 405)
id Related Disease Score Top Affiliating Genes
1 capillary hemangioma 31.7 EDN1 MTHFR NOS3 VEGFA
2 lupus erythematosus 30.4 ACE CRP PLAT SELP VWF
3 limb ischemia 29.9 ACE ADIPOQ APOE CRP EDN1 INS
4 renovascular hypertension 29.8 EDN1 NOS3 VCAM1
5 hypertriglyceridemia 29.6 APOA1 APOB APOE
6 ischemic optic neuropathy 29.5 ACE CRP SELP SERPINE1 VEGFA VWF
7 myocardial infarction 29.4 ACE ADIPOQ APOA1 APOB APOE CBS
8 peripheral vascular disease 12.3
9 fibro-adipose vascular anomaly 12.2
10 hepatic vascular disease 12.1
11 retinal vascular disease 11.9
12 sternal cyst vascular anomalies 11.8
13 polyneuropathy in collagen vascular disease 11.7
14 conjunctival vascular disease 11.7
15 male genital organ vascular disease 11.7
16 buerger disease 11.2
17 arteriosclerosis 11.2
18 bier spots 11.1
19 mixed connective tissue disease 11.0
20 renal artery disease 11.0
21 klippel-trenaunay-weber syndrome 11.0
22 atherosclerosis 10.9
23 artery disease 10.9
24 ischemia 10.9
25 thrombosis 10.9
26 vasculitis 10.9
27 angiodysplasia 10.8
28 cerebral cavernous malformations-1 10.8
29 sturge-weber syndrome, somatic, mosaic 10.8
30 aberrant subclavian artery 10.8
31 cutis laxa, autosomal recessive, type ia 10.8
32 mesenteric artery ischemia 10.7
33 vascular myelopathy 10.7
34 cerebral cavernous malformations-2 10.7
35 vascular malformation, primary intraosseous 10.7
36 adams-oliver syndrome 5 10.7
37 flna-related periventricular nodular heterotopia 10.7
38 adams-oliver syndrome 1 10.7
39 adams-oliver syndrome 6 10.7
40 cerebral cavernous malformations 3 10.7
41 clove syndrome, somatic 10.7
42 arteriovenous malformation 10.7
43 cholesterol embolism 10.5
44 fabry disease 10.5
45 supine hypotensive syndrome 10.5
46 intracranial arteriosclerosis 10.5
47 loeys-dietz syndrome 1 10.5
48 vein disease 10.5
49 exudative vitreoretinopathy 10.5
50 hepatic veno-occlusive disease 10.5

Comorbidity relations with Vascular Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Heart Disease
Hypertension, Essential Ischemic Heart Disease
Peripheral Vascular Disease

Graphical network of the top 20 diseases related to Vascular Disease:



Diseases related to Vascular Disease

Symptoms & Phenotypes for Vascular Disease

UMLS symptoms related to Vascular Disease:


angina pectoris, chest pain, edema, flushing, leg cramps, warm skin, vein pain

GenomeRNAi Phenotypes related to Vascular Disease according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased free cholesterol GR00340-A-2 9.26 APOA1 APOB APOE SELP
2 Increased LDL uptake GR00340-A-1 8.8 APOA1 APOE SELP

MGI Mouse Phenotypes related to Vascular Disease:

44 (show all 16)
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.49 PON1 SELE SELP SERPINE1 VCAM1 VEGFA
2 homeostasis/metabolism MP:0005376 10.45 ACE ADIPOQ APOA1 APOB APOE CRP
3 growth/size/body region MP:0005378 10.37 ACE ADIPOQ APOB APOE EDN1 INS
4 cellular MP:0005384 10.36 VCAM1 VEGFA VWF ADIPOQ APOA1 APOB
5 immune system MP:0005387 10.35 ACE ADIPOQ APOB APOE CCL2 CRP
6 hematopoietic system MP:0005397 10.29 VWF ACE ADIPOQ APOE INS NOS3
7 mortality/aging MP:0010768 10.28 INS MTHFR NOS3 PLAT SELE SELP
8 endocrine/exocrine gland MP:0005379 10.19 ACE ADIPOQ APOA1 APOE EDN1 INS
9 liver/biliary system MP:0005370 10.17 APOB APOE INS NOS3 SELE SELP
10 integument MP:0010771 10.11 ADIPOQ APOA1 APOE INS MTHFR SELE
11 muscle MP:0005369 9.97 APOB APOE EDN1 INS NOS3 PLAT
12 renal/urinary system MP:0005367 9.97 ACE ADIPOQ APOE EDN1 INS NOS3
13 reproductive system MP:0005389 9.91 ACE APOB APOE INS MTHFR NOS3
14 respiratory system MP:0005388 9.76 ADIPOQ APOE NOS3 PLAT SELE SELP
15 skeleton MP:0005390 9.61 INS MTHFR NOS3 PLAT SELP VEGFA
16 vision/eye MP:0005391 9.28 APOB APOE INS MTHFR NOS3 PLAT

Drugs & Therapeutics for Vascular Disease

Drugs for Vascular Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1001)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
2
Methyltestosterone Approved Phase 4 58-18-4 6010
3
Testosterone Approved, Investigational Phase 4 58-22-0 6013
4
Verteporfin Approved, Investigational Phase 4 129497-78-5
5
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 33069-62-4 36314
6
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
7
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1 2216-51-5 16666
8
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
9
Ticlopidine Approved Phase 4,Phase 2,Phase 3,Phase 1 55142-85-3 5472
10
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 119141-88-7 4594 9579578
11
Famotidine Approved Phase 4 76824-35-6 3325
12
Histamine Approved, Investigational Phase 4,Phase 1 75614-87-8, 51-45-6 774
13
Enalapril Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 75847-73-3 5362032 40466924
14
Enalaprilat Approved Phase 4,Phase 3,Phase 2,Phase 1 76420-72-9 6917719
15
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
16
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2 55-56-1 9552079 2713
17
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
18
Metronidazole Approved Phase 4 443-48-1 4173
19
Povidone-iodine Approved Phase 4 25655-41-8
20
Teicoplanin Approved Phase 4 61036-62-2
21
Sevelamer Approved Phase 4 52757-95-6, 152751-57-0 3085017
22
Dalteparin Approved Phase 4,Phase 3,Phase 2,Phase 1 9041-08-1
23
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
24
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
25
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
26
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
27
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
28
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
29
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
30
Cilostazol Approved Phase 4,Phase 3,Phase 2,Phase 1 73963-72-1 2754
31
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
32
Pravastatin Approved Phase 4,Phase 3,Phase 2 81093-37-0 54687
33
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
34
Amiloride Approved Phase 4,Phase 3,Phase 1 2016-88-8, 2609-46-3 16231
35
Amlodipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 88150-42-9 2162
36
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 144701-48-4 65999
37
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-93-5 3639
38
Clonidine Approved Phase 4,Phase 2,Early Phase 1 4205-90-7 2803
39
Spironolactone Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1952-01-7, 52-01-7 5833
40
Losartan Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 114798-26-4 3961
41
Olmesartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 144689-24-7, 144689-63-4 158781 130881
42
Bisoprolol Approved Phase 4,Phase 3,Early Phase 1 66722-44-9 2405
43
Captopril Approved Phase 4,Early Phase 1 62571-86-2 44093
44
Nitrendipine Approved Phase 4,Phase 3,Phase 2 39562-70-4 4507
45
Nebivolol Approved, Investigational Phase 4,Phase 3,Phase 2 152520-56-4, 99200-09-6, 118457-14-0 71301
46
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
47
Oxymetazoline Approved Phase 4,Phase 2,Phase 3,Phase 1 1491-59-4 4636
48
Phenylephrine Approved Phase 4,Phase 2,Phase 3,Phase 1 59-42-7 6041
49
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
50
Carvedilol Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 72956-09-3 2585

Interventional clinical trials:

(show top 50) (show all 5122)
id Name Status NCT ID Phase
1 Spinal Cord Stimulation (SCS) in Refractory Angina Unknown status NCT00121654 Phase 4
2 Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery Unknown status NCT01889498 Phase 4
3 Testosterone for Peripheral Vascular Disease Unknown status NCT00504712 Phase 4
4 Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) Unknown status NCT02092532 Phase 4
5 Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy Unknown status NCT02072408 Phase 4
6 Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease Unknown status NCT00986752 Phase 4
7 Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery Unknown status NCT01083394 Phase 4
8 Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery Unknown status NCT01147419 Phase 4
9 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) Unknown status NCT01173094 Phase 4
10 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) Unknown status NCT01171703 Phase 4
11 Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy Unknown status NCT01743014 Phase 4
12 Early Warning and Optimization Strategy in Carotid Endarterectomy Unknown status NCT01210937 Phase 4
13 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4
14 Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia Unknown status NCT00978159 Phase 4
15 LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients Unknown status NCT02077257 Phase 4
16 Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human Unknown status NCT01069042 Phase 4
17 The Amputation Surgical Site Infection Trial (ASSIT) Unknown status NCT02018094 Phase 4
18 How Bone is Made in Children Receiving Dialysis Unknown status NCT01799317 Phase 4
19 Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis Unknown status NCT00640731 Phase 4
20 Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Unknown status NCT01245998 Phase 4
21 Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure Unknown status NCT00716573 Phase 4
22 Lovaza Mechanisms of Action Unknown status NCT01301794 Phase 4
23 Residual Platelet Activity In Advanced Peripheral Artery Disease Unknown status NCT01627431 Phase 4
24 Platelets Induced Vasodilation, in Vitro and in Vivo Study Unknown status NCT00152646 Phase 4
25 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
26 Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events Unknown status NCT00886574 Phase 4
27 Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Unknown status NCT01023373 Phase 4
28 Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD Unknown status NCT02008786 Phase 4
29 Testosterone Replacement in Older Men and Atherosclerosis Progression Unknown status NCT00287586 Phase 4
30 COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent Unknown status NCT00920283 Phase 4
31 Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Unknown status NCT01768585 Phase 4
32 Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease Unknown status NCT00144937 Phase 4
33 Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment Unknown status NCT01761786 Phase 4
34 The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Unknown status NCT01325818 Phase 4
35 Targeting Microvascular Dysfunction in Young Hypertensive Patients Unknown status NCT01047423 Phase 4
36 Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension Unknown status NCT01308983 Phase 4
37 Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings Unknown status NCT01793194 Phase 4
38 Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients Unknown status NCT01011660 Phase 4
39 Treatment of HYpertension: Morning Versus Evening Unknown status NCT02214498 Phase 4
40 Resistant Hypertension Optimal Treatment Unknown status NCT01643434 Phase 4
41 Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome Unknown status NCT01271374 Phase 4
42 Hypertension Control Based on Home Blood Pressure Unknown status NCT00198562 Phase 4
43 Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension Unknown status NCT01472796 Phase 4
44 BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study) Unknown status NCT02398929 Phase 4
45 Treatment of Hypertension in Tibetan Adult Population Unknown status NCT02217852 Phase 4
46 The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension Unknown status NCT02156024 Phase 4
47 Comparative Study of the Effects of Telmisartan and Nebivolol Unknown status NCT02057328 Phase 4
48 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4
49 Compared Efficacy and Tolerance of Two Vasopressors Used to Treat Preoperative Hypotension During Carotid Surgery Unknown status NCT01794273 Phase 4
50 Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension Unknown status NCT01519635 Phase 4

Search NIH Clinical Center for Vascular Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: aneurysm

Genetic Tests for Vascular Disease

Anatomical Context for Vascular Disease

MalaCards organs/tissues related to Vascular Disease:

39
Heart, Endothelial, Spinal Cord, Brain, Kidney, Skin, Smooth Muscle

Publications for Vascular Disease

Articles related to Vascular Disease:

(show top 50) (show all 1770)
id Title Authors Year
1
PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study. ( 28060188 )
2017
2
Restenosis in Hemodialytic Fistulas and Chronic Kidney Disease-Associated Vascular Disease: Two Pathologies Driven by Metakaryotic Stem Cells. ( 28535522 )
2017
3
In Patients with Vascular Disease, Treating Sleep Apnea Does Not Reduce the Risk of Cardiovascular Events. ( 28084709 )
2017
4
MicroRNAs: The Swing Voters in Vascular Disease Waiting for a Program. ( 28057779 )
2017
5
Vascular disease: Ticagrelor not superior to clopidogrel for PAD. ( 27905478 )
2017
6
Atherosclerotic vascular diseases have really the same risk factors? Comparison between large abdominal aortic aneurysm and obstructive non-coronary arterial disease. ( 28509621 )
2017
7
Perivascular adipose tissue inflammation in vascular disease. ( 28063251 )
2017
8
Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells. ( 27984756 )
2017
9
Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. ( 28077689 )
2017
10
The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study. ( 28065166 )
2017
11
Polyarteritis nodosa presenting as peripheral vascular disease and acute limb ischemia. ( 27853042 )
2017
12
Reduced subclinical carotid vascular disease and arterial stiffness in vegetarian men: The CARVOS Study. ( 28062141 )
2017
13
Gut microbiota in vascular disease: Therapeutic target? ( 28056754 )
2017
14
Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease. ( 27939641 )
2017
15
Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients? ( 27577528 )
2016
16
Vascular Disease in Young Indians (20-40 years): Role of Hypertension. ( 27656492 )
2016
17
Peripheral vascular disease in diabetic foot- A new trend. ( 27727607 )
2016
18
Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA). ( 27145089 )
2016
19
Autoantigens targeted in scleroderma patients with vascular disease are enriched in endothelial lineage cells. ( 27159521 )
2016
20
Combination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease. ( 27198152 )
2016
21
Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease. ( 27492512 )
2016
22
The association between blood group and the risk of vascular disease in Quebec blood donors. ( 27177404 )
2016
23
BMPR2 mutation is a potential predisposing genetic risk factor for congenital heart disease associated pulmonary vascular disease. ( 27002414 )
2016
24
Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets. ( 27976387 )
2016
25
Vascular disease in the older adult. ( 27899936 )
2016
26
An Experimental Model of Peripheral Vascular Disease Involving the Intravenous Injection of Oral Bacteria. ( 28018496 )
2016
27
Comparison of colour duplex ultrasound & ankle brachial index in peripheral vascular disease in type 2 diabetes. ( 27727957 )
2016
28
Anesthesia for Patients with Peripheral Vascular Disease and Cardiac Dysfunction. ( 27816134 )
2016
29
Increased peripheral vascular disease risk progressively constrains perfusion adaptability in the skeletal muscle microcirculation. ( 26702145 )
2016
30
PET/MR Imaging in Vascular Disease: Atherosclerosis and Inflammation. ( 27593251 )
2016
31
Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism. ( 27993872 )
2016
32
Left-to-Right Shunts: Is There No Window for Repair Before Pulmonary Vascular Disease and Myocardial Fibrotic Remodeling Develop? ( 27601368 )
2016
33
Pain management in patients with vascular disease. ( 27566812 )
2016
34
Accelerated Vascular Aging as a Paradigm for Hypertensive Vascular Disease: Prevention and Therapy. ( 27118295 )
2016
35
The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease. ( 26618253 )
2016
36
Value of 18F-FDG PET/CT in diagnosing chronic Q fever in patients with central vascular disease. ( 27571945 )
2016
37
Mortality After Nontraumatic Major Amputation Among Patients WithA Diabetes and Peripheral Vascular Disease: A Systematic Review. ( 26898398 )
2016
38
Mitochondrial Respiration after One Session of Calf Raise Exercise in Patients with Peripheral Vascular Disease and Healthy Older Adults. ( 27760222 )
2016
39
Vascular diseases: aortitis, aortic aneurysms, and vascular calcification. ( 27526100 )
2016
40
Hemorheological parameters better classify metabolic syndrome than novel cardiovascular risk factors and peripheral vascular disease marker. ( 26890105 )
2016
41
Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. ( 27165838 )
2016
42
Prevalence of asymptomatic peripheral vascular disease in patients with type-2 diabetes mellitus by colour doppler study. ( 27728049 )
2016
43
The Dilemma of Breast Cancer Treatment and Existing Collagen Vascular Disease: A Case of Scleroderma and Review of the Literature. ( 27124200 )
2016
44
P66(Shc)-SIRT1 Regulation of Oxidative Stress Protects Against Cardio-cerebral Vascular Disease. ( 27578018 )
2016
45
Vascular Disease in Young Indians (20-40 years): Role of Dyslipidemia. ( 27630892 )
2016
46
Trimetazidine hydrochloride as a new treatment for patients with peripheral vascular disease--an exploratory trial. ( 26813473 )
2016
47
Vascular disease risk in type 2 diabetes: high sugars, fluctuating sugars, both? ( 27112078 )
2016
48
Identifying beliefs about smoking in patients with peripheral vascular disease. ( 27863591 )
2016
49
Adult lead exposure increases blood-retinal permeability: A risk factor for retinal vascular disease. ( 27663850 )
2016
50
Cell Therapy Applications for Retinal Vascular Diseases: Diabetic Retinopathy and Retinal Vein Occlusion. ( 27116667 )
2016